EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY-NC 4.0

Direct Oral Anticoagulants Versus Vitamin K Antagonists in Cerebral Venous Thrombosis: A Systematic Review and Meta-Analysis of 4,929 Patients

Muhammad Hassan Waseem iD, Zain Ul Abideen, Areeba Shoaib, Nohela Rehman, Muhammad Osama, Barka Sajid, Muhammad Mukhlis, Sania Aimen, Muhammad Wajih Ansari, Rowaid Ahmad, Zara Fahim, Ameer Haider Cheema und 2 weitere

Clinical and Applied Thrombosis/Hemostasis · 2025

DOI: 10.1177/10760296251405417 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Clinical and Applied Thrombosis/Hemostasis, 2025. Verfasst von Muhammad Hassan Waseem und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Allama Iqbal Medical College, Lahore, Pakistan. Hauptthemen laut MEDLINE: Vitamin K, Anticoagulants, Intracranial Thrombosis, Venous Thrombosis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cerebral venous thrombosis (CVT), a rare cause of stroke, primarily occurs in young individuals. The established treatment regimen involves anticoagulation with low molecular weight heparin (LMWH) and vitamin K antagonists (VKA). Although direct oral anticoagulants (DOACs) have emerged as a promising alternative, their efficacy and safety remain unclear. This meta-analysis compared the efficacy and safety of DOACs versus VKA in managing CVT.

Methods

Electronic databases, including PubMed, Cochrane Library, and ScienceDirect, were searched from inception until April 2025. Risk ratios (RR) with a 95% Confidence interval (CI) were pooled under the random effects model in the Review Manager 5.4.1. Quality assessment was done through the Cochrane risk of bias (RoB 2.0) tool and the Newcastle Ottawa Scale (NOS). Subgroup analyses based on study design and different types of DOACs were carried out.

Results

Thirty-one studies, including five randomized controlled trials (RCTs) and 26 observational studies, were included in this meta-analysis. Our analysis showed a significant reduction in the risk of recurrent venous thromboembolism (VTE) in the DOACs arm compared to VKA (RR = 0.84; 95%CI: [0.71,0.99]; p = 0.04; I 2 = 0%). Similarly, the DOACs showed significant superiority over VKA regarding the intracranial hemorrhage (ICH) (RR = 0.67; 95%CI: [0.50,0.89]; p = 0.007; I 2 = 0%). Other endpoints, including major hemorrhage (RR = 0.70; 95%CI:[0.42,1.15]; p = 0.16; I 2 = 0%), all-cause mortality (RR = 0.96; 95%CI:[0.68,1.35]; p = 0.81; I 2 = 0%), and full recanalization (RR = 0.92; 95%CI:[0.82,1.03]; p = 0.16; I 2 = 21%), are comparable between the two arms.

Conclusion

DOACs showed a significant reduction in the risk of recurrent VTE and ICH compared to VKA, whereas other endpoints are comparable. Further RCTs with a robust sample size are required to validate and confirm these findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vitamin KAnticoagulantsIntracranial ThrombosisVenous ThrombosisHumansAdministration, Oral

Stichwörter der Autor:innen

anticoagulationcerebral venous thrombosisdirect oral anticoagulantsvitamin K antagonistwarfarin

Substanzen

Vitamin KAnticoagulants

Autor:innen und Institutionen

  • Department of Neurology, Allama Iqbal Medical College, Lahore, Pakistan.
  • Department of Neurology, King Edward Medical University, Lahore, Pakistan.
  • Department of Neurology, Dow University of Health Sciences, Karachi, Pakistan.
  • Department of Neurology, Hayatabad Medical Complex, Peshawar, Pakistan.
  • Department of Neurology, Jinnah Sindh Medical University, Karachi, Pakistan.
  • Department of Neurology, Ayub Medical College, Abbottabad, Pakistan.

ORCID-Profile: Muhammad Hassan Waseem, Pawan Kumar Thada

Zitieren

APA

Waseem, M. H., Abideen, Z. U., Shoaib, A., Rehman, N., Osama, M., Sajid, B., Mukhlis, M., Aimen, S., Ansari, M. W., Ahmad, R., Fahim, Z., Cheema, A. H., Zahid, M. B., & Thada, P. K. (2025). Direct Oral Anticoagulants Versus Vitamin K Antagonists in Cerebral Venous Thrombosis: A Systematic Review and Meta-Analysis of 4,929 Patients. Clinical and Applied Thrombosis/Hemostasis. https://doi.org/10.1177/10760296251405417

Vancouver

Waseem MH, Abideen ZU, Shoaib A, Rehman N, Osama M, Sajid B, et al. Direct Oral Anticoagulants Versus Vitamin K Antagonists in Cerebral Venous Thrombosis: A Systematic Review and Meta-Analysis of 4,929 Patients. Clinical and Applied Thrombosis/Hemostasis. 2025. doi:10.1177/10760296251405417

BibTeX
@article{Waseem2025,
  author = {Waseem, Muhammad Hassan and Abideen, Zain Ul and Shoaib, Areeba and Rehman, Nohela and Osama, Muhammad and Sajid, Barka and Mukhlis, Muhammad and Aimen, Sania and Ansari, Muhammad Wajih and Ahmad, Rowaid and Fahim, Zara and Cheema, Ameer Haider and Zahid, Muhammad Bilal and Thada, Pawan Kumar},
  title = {Direct Oral Anticoagulants Versus Vitamin K Antagonists in Cerebral Venous Thrombosis: A Systematic Review and Meta-Analysis of 4,929 Patients},
  journal = {Clinical and Applied Thrombosis/Hemostasis},
  year = {2025},
  doi = {10.1177/10760296251405417}
}
Kostenlos starten →